MTOR and colorectal carcinoma: The diverse molecular pathways related to CRC, like JAK/STAT, Wnt/β catenin, EMT, PI3K/AKT, and mTOR, can be regulated by bioactive compounds promoting apoptosis, inhibiting or decreasing cell growth and proliferation, reducing inflammation, eliminating cancer stem cells, and avoiding chemoresistance.